메뉴 건너뛰기




Volumn 52, Issue 3, 2012, Pages 339-346

Effect of HMGCR variant alleles on low-density lipoprotein cholesterol-lowering response to atorvastatin in healthy Korean subjects

Author keywords

atorvastatin; cholesterol lowering drugs; HMG CoA reductase; lipids; pharmacogenetics

Indexed keywords

ATORVASTATIN; CREATINE KINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

EID: 84860174535     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270011398239     Document Type: Article
Times cited : (27)

References (20)
  • 1
    • 0032554688 scopus 로고    scopus 로고
    • Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial
    • Sacks FM, Moye LA, Davis BR, et al. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation. 1998 ; 97: 1446-1452
    • (1998) Circulation , vol.97 , pp. 1446-1452
    • Sacks, F.M.1    Moye, L.A.2    Davis, B.R.3
  • 2
    • 0034647158 scopus 로고    scopus 로고
    • Statins and risk of coronary heart disease
    • LaRosa JC. Statins and risk of coronary heart disease. JAMA. 2000 ; 283: 2935-2936
    • (2000) JAMA , vol.283 , pp. 2935-2936
    • Larosa, J.C.1
  • 4
    • 41149174566 scopus 로고    scopus 로고
    • Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment
    • Krauss RM, Mangravite LM, Smith JD, et al. Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment. Circulation. 2008 ; 117: 1537-1544
    • (2008) Circulation , vol.117 , pp. 1537-1544
    • Krauss, R.M.1    Mangravite, L.M.2    Smith, J.D.3
  • 5
    • 49149095635 scopus 로고    scopus 로고
    • Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin
    • Medina MW, Gao F, Ruan W, Rotter JI, Krauss RM. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin. Circulation. 2008 ; 118: 355-362
    • (2008) Circulation , vol.118 , pp. 355-362
    • Medina, M.W.1    Gao, F.2    Ruan, W.3    Rotter, J.I.4    Krauss, R.M.5
  • 6
    • 77649197488 scopus 로고    scopus 로고
    • Association of the functional variant in the 3-hydroxy-3-methylglutaryl- coenzyme a reductase gene with low-density lipoprotein-cholesterol in Japanese
    • Hiura Y, Tabara Y, Kokubo Y, et al. Association of the functional variant in the 3-hydroxy-3-methylglutaryl-coenzyme a reductase gene with low-density lipoprotein-cholesterol in Japanese. Circ J. 2010 ; 74: 518-522
    • (2010) Circ J , vol.74 , pp. 518-522
    • Hiura, Y.1    Tabara, Y.2    Kokubo, Y.3
  • 7
    • 33644609683 scopus 로고    scopus 로고
    • Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: The Cholesterol and Pharmacogenetics (CAP) Study
    • Simon JA, Lin F, Hulley SB, et al. Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol. 2006 ; 97: 843-850
    • (2006) Am J Cardiol , vol.97 , pp. 843-850
    • Simon, J.A.1    Lin, F.2    Hulley, S.B.3
  • 8
    • 19744373433 scopus 로고    scopus 로고
    • Best-selling human medicines 2002-2004
    • Maggon K. Best-selling human medicines 2002-2004. Drug Discov Today. 2005 ; 10: 739-742
    • (2005) Drug Discov Today , vol.10 , pp. 739-742
    • Maggon, K.1
  • 9
    • 25844530136 scopus 로고    scopus 로고
    • Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers
    • Chung JY, Cho JY, Yu KS, et al. Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers. Clin Pharmacol Ther. 2005 ; 78: 342-350
    • (2005) Clin Pharmacol Ther , vol.78 , pp. 342-350
    • Chung, J.Y.1    Cho, J.Y.2    Yu, K.S.3
  • 10
    • 33646198187 scopus 로고    scopus 로고
    • Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin
    • Igel M, Arnold KA, Niemi M, et al. Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin. Clin Pharmacol Ther. 2006 ; 79: 419-426
    • (2006) Clin Pharmacol Ther , vol.79 , pp. 419-426
    • Igel, M.1    Arnold, K.A.2    Niemi, M.3
  • 11
    • 33751096467 scopus 로고    scopus 로고
    • SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
    • Pasanen MK, Neuvonen M, Neuvonen PJ, Niemi M. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. Pharmacogenet Genomics. 2006 ; 16: 873-879
    • (2006) Pharmacogenet Genomics , vol.16 , pp. 873-879
    • Pasanen, M.K.1    Neuvonen, M.2    Neuvonen, P.J.3    Niemi, M.4
  • 12
    • 0038209381 scopus 로고    scopus 로고
    • Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics
    • Nishizato Y, Ieiri I, Suzuki H, et al. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther. 2003 ; 73: 554-565
    • (2003) Clin Pharmacol Ther , vol.73 , pp. 554-565
    • Nishizato, Y.1    Ieiri, I.2    Suzuki, H.3
  • 13
    • 72849141790 scopus 로고    scopus 로고
    • Transporter pharmacogenetics and statin toxicity
    • Niemi M. Transporter pharmacogenetics and statin toxicity. Clin Pharmacol Ther. 2010 ; 87: 130-133
    • (2010) Clin Pharmacol Ther , vol.87 , pp. 130-133
    • Niemi, M.1
  • 14
    • 49949104757 scopus 로고    scopus 로고
    • SLCO1B1 variants and statin-induced myopathy-a genomewide study
    • Link E, Parish S, Armitage J, et al. SLCO1B1 variants and statin-induced myopathy-a genomewide study. N Engl J Med. 2008 ; 359: 789-799
    • (2008) N Engl J Med , vol.359 , pp. 789-799
    • Link, E.1    Parish, S.2    Armitage, J.3
  • 15
    • 34548009561 scopus 로고    scopus 로고
    • SLCO1B1 521T->C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients
    • Zhang W, Chen BL, Ozdemir V, et al. SLCO1B1 521T->C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients. Br J Clin Pharmacol. 2007 ; 64: 346-352
    • (2007) Br J Clin Pharmacol , vol.64 , pp. 346-352
    • Zhang, W.1    Chen, B.L.2    Ozdemir, V.3
  • 16
    • 84860181689 scopus 로고    scopus 로고
    • New York, NY: Pfizer Inc;
    • New York, NY: Pfizer Inc ;
  • 17
    • 25844458977 scopus 로고    scopus 로고
    • Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment
    • Lee E, Ryan S, Birmingham B, et al. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment. Clin Pharmacol Ther. 2005 ; 78: 330-341
    • (2005) Clin Pharmacol Ther , vol.78 , pp. 330-341
    • Lee, E.1    Ryan, S.2    Birmingham, B.3
  • 18
    • 0025345124 scopus 로고
    • Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol
    • Reihner E, Rudling M, Stahlberg D, et al. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med. 1990 ; 323: 224-228
    • (1990) N Engl J Med , vol.323 , pp. 224-228
    • Reihner, E.1    Rudling, M.2    Stahlberg, D.3
  • 19
    • 77949906521 scopus 로고    scopus 로고
    • Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells
    • Pocathikorn A, Taylor RR, Mamotte CD. Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells. Clin Exp Pharmacol Physiol. 2010 ; 37: 471-476
    • (2010) Clin Exp Pharmacol Physiol , vol.37 , pp. 471-476
    • Pocathikorn, A.1    Taylor, R.R.2    Mamotte, C.D.3
  • 20
    • 77953962940 scopus 로고    scopus 로고
    • Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin
    • Mangravite LM, Medina MW, Cui J, et al. Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin. Arterioscler Thromb Vasc Biol. 2010 ; 30: 1485-1492
    • (2010) Arterioscler Thromb Vasc Biol , vol.30 , pp. 1485-1492
    • Mangravite, L.M.1    Medina, M.W.2    Cui, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.